简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-10-17 10:21 PotNetwork Holdings, Inc. Files Form 10 To Become SEC Reporting Company
2018-10-16 11:57 HEX Debuts Coin Listing on Singapore Cryptocurrency Exchange BCoin.sg
2018-10-15 15:22 Results from Pradaxa® RE-SPECT ESUS® and RE-SPECT CVT® trials to be presented at the 11th World Stroke Congress
2018-10-12 14:36 Heart Center Dresden to Be First Commercial Clinical Site for Imricor
2018-10-11 16:47 Delos and EDGE Technologies Collaborate to Advance Smart-Healthy Building Management Systems
2018-10-11 11:28 Plant Oil-Extracted Active Ingredient, Blue Oléoactif®, Wins Silver For Hallstar at in-cosmetics Latin America
2018-10-11 10:21 New Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at ECTRIMS 2018
2018-10-11 10:18 New analysis estimates the positive impact of empagliflozin on prolonging life expectancy in adults with type 2 diabetes and established cardiovascular disease
2018-10-11 10:16 Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing
2018-10-10 10:49 Brightree Launches BrightreeCARE App for Home Health and Hospice Aides
2018-10-09 18:01 Life Biosciences Acquires Lua, Pioneering AI-Driven Healthcare Platform
2018-10-09 15:54 STEPWORLD Co., Ltd. : Commencing Full-fledged Sales in China of "HELASLIM," a Tremendously Popular Supplement in Japan
2018-10-09 13:47 PharmAbcine Announces FDA Accepts IND Application of TTAC-0001 for the Treatment of Recurrent Glioblastoma
2018-10-09 10:37 Seattle Genetics and Takeda Announce Positive Results from Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline CD30-Expressing Peripheral T-Cell Lymphoma
2018-10-09 09:40 Huntsman Cancer Institute at the University of Utah Selects Mevion to Provide Compact Single-Room System for the First Proton Therapy Center in Utah
2018-10-09 09:29 Celgene Announces Phase 3 STYLE Study of OTEZLA® (apremilast) in Moderate to Severe Scalp Psoriasis Met Primary Endpoint
2018-10-08 18:43 New Study Evaluates the Ability of Masimo ORi™ to Help Clinicians Reduce Hyperoxemia in Mechanically Ventilated ICU Patients
2018-10-08 14:14 Takeda Establishes Record Date for the Extraordinary General Meeting of Shareholders
2018-10-08 10:40 Boehringer Ingelheim and Lilly present full results of Trajenta®’s CARMELINA® cardiovascular outcome trial
2018-10-08 10:35 Boehringer Ingelheim and Lilly present full results from EASE Phase III programme for empagliflozin as adjunct to insulin in type 1 diabetes

Business Wire Weibo

Press Releases

Latest Releases